Shriyansh Srivastav – författare

Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine gives readers a comprehensive and up-to-date resource on the latest developments and trends in the field of cancer pharmacology. It serves as a valuable reference for researchers, scientists, clinicians, and other professionals involved in cancer research, pharmacology, oncology, and personalized medicine. In recent years, there have been significant breakthroughs in understanding the molecular mechanisms of cancer and the development of targeted therapies. Additionally, personalized medicine has emerged as a promising approach to tailor treatments based on an individual's genetic profile, tumor characteristics, and other factors. These developments have the potential to revolutionize cancer treatment and improve patient outcomes. This book covers such developments. - Provides a comprehensive overview of emerging trends in cancer pharmacology, offering readers the opportunity to stay up-to-date- Serves as a valuable resource for understanding molecular targets and personalized medicine approaches in cancer pharmacology- Provides insights into new avenues for drug discovery, development, and optimization, thereby facilitating more targeted and effective therapies